Toggle Main Menu Toggle Search

Open Access padlockePrints

Changes in iPSC-astrocyte morphology reflect Alzheimer’s disease patient clinical markers

Lookup NU author(s): Professor Alan ThomasORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Abstract

© The Author(s) 2024.Human induced pluripotent stem cells (iPSCs) provide powerful cellular models of Alzheimer’s disease (AD) and offer many advantages over nonhuman models, including the potential to reflect variation in individual-specific pathophysiology and clinical symptoms. Previous studies have demonstrated that iPSC-neurons from individuals with Alzheimer’s disease (AD) reflect clinical markers, including β-amyloid (Aβ) levels and synaptic vulnerability. However, despite neuronal loss being a key hallmark of AD pathology, many risk genes are predominantly expressed in glia, highlighting them as potential therapeutic targets. In this work iPSC-derived astrocytes were generated from a cohort of individuals with high versus low levels of the inflammatory marker YKL-40, in their cerebrospinal fluid (CSF). iPSC-derived astrocytes were treated with exogenous Aβ oligomers and high content imaging demonstrated a correlation between astrocytes that underwent the greatest morphology change from patients with low levels of CSF-YKL-40 and more protective APOE genotypes. This finding was subsequently verified using similarity learning as an unbiased approach. This study shows that iPSC-derived astrocytes from AD patients reflect key aspects of the pathophysiological phenotype of those same patients, thereby offering a novel means of modelling AD, stratifying AD patients and conducting therapeutic screens.


Publication metadata

Author(s): Rowland HA, Miller G, Liu Q, Li S, Sharp NR, Ng B, Wei T, Arunasalam K, Koychev I, Hedegaard A, Ribe EM, Chan D, Chessell T, Kocagoncu E, Lawson J, Malhotra P, Ridha BH, Rowe JB, Thomas AJ, Zamboni G, Zetterberg H, Cader MZ, Wade-Martins R, Lovestone S, Nevado-Holgado A, Kormilitzin A, Buckley NJ

Publication type: Article

Publication status: Published

Journal: Stem Cells

Year: 2025

Volume: 43

Issue: 3

Print publication date: 01/03/2025

Online publication date: 20/12/2024

Acceptance date: 03/09/2024

Date deposited: 08/04/2025

ISSN (print): 1066-5099

ISSN (electronic): 1549-4918

Publisher: Oxford University Press

URL: https://doi.org/10.1093/stmcls/sxae085

DOI: 10.1093/stmcls/sxae085

Data Access Statement: The data underlying this article will be shared on reasonable request to the corresponding authors.

PubMed id: 39704342


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
115439
European Federation of Pharmaceutical Industries and Associations
European Union Seventh Framework Programme
FP7/2007e2013
Innovative Medicines Initiative Joint Undertaking
MR/L023784/2
Medical Research Council
MR/M024962/1
MR/N029941/1Medical Research Council (MRC)
National Institute for Health Research

Share